About Vice-Principal Research皇冠体育鈥檚 Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,358,933 entitled, "Compounds and Methods for Inhibiting CYP26 Enzymes," on June 14, 2022 to Donald Cameron, Martin Petkovich, and Uttam Saha. The patent relates to compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes.
U.S. Patent No. 11,358,933 (PDF, 1.4 MB)US11358933_Cameron (1).pdf